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Bambusa tulda (Poaceae) is one of the most valuable bamboo species in terms of health-promoting effects. The goal of 
this research work was to carry out the in-vivo acute toxicity, anti-diabetic and anti-oxidative activities of hydro-methanolic 
extract of B. tulda leaves. The median lethal dose (LD50) of the hydro-methanolic extract of B. tulda leaves was found to be 
6088.13 mg/kg body weight in mice. Supplementing the low (100 mg/kg) and high dose (200 mg/kg) of B. tulda leaf extract 
showed significant elevation in the endogenous enzymes level of superoxide dismutase (24.81%) and glutathione peroxidase 
(31.60%) with a decline in malondialdehyde levels (21.90%) when compared to untreated alloxan-induced diabetic control 
rats. The histopathological assessment of pancreas also showed an increase in β-cells, though not at a significant level. 
Hence the presence of phyto-constituents substantiates the pharmacological activities of hydro-methanolic extract of B. 
tulda leaf particularly as a potential candidate for anti-diabetic activity. However, detailed studies are needed to elucidate its 
exact mechanism of action against diabetes. 
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Plants are used in Ayurveda, an ancient Indian 
traditional knowledge, to cure and manage various 
ailments since the days of yore and bamboo is no 
exception1-3. As resourceful natural antioxidants and 
their bioactive compounds, bamboo species have been 
well documented in the recent years4. The major 
documented species are Bambusa vulgaris ‘Vittata’5,6, 
Dendrocalamus strictus7, Dendrocalamus hamiltonii8, 
Phyllostachys edulis9, Sasa borealis10, Bambusa 
balcooa11,12. There are only a few reports of scientific 
evidences to name the compounds present in 
bamboo8,11 though, the authors have not come across 
any document on the mechanism of action with 
regards to disease prevention. However, only a few 
scientific documentations are available to validate the 
anti-hyperglycemic activity of “Giant Grass” bamboo 
species11,13-16. Few bamboo species such as B. 
vulgaris, B. pallida, B. balcooa, D. hamiltonii and D. 
sikkimensis had shown prominent anti-diabetic 
activity in vitro using glucose oxidase method 17. 
Bambusa tulda Roxb. (family: Poaceae) is dark 
green in colour, attaining a height of about 17 m and a 
diameter of about 16.51 cm4. Popular among the local 
tribe as Owa gubwai (Bodo), its tender shoots are 
widely consumed by the Bodos in various culinary 
preparations18. Though common in the wild, Bambusa 
tulda is also very frequent in the homestead 
plantation. It is closely associated with the livelihood 
of the rustic tribes in various ways19-23. 
Bambusa tulda forms an ingredient of the traditional 
medicine used by the people of Northeast India24,25. The 
shoot exudates (juice) are effective in treating nail injury 
when used fresh26. The fermented shoot exudates of 
Bambusa tulda forms a component of the traditional 
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formulation used in tumor management26. Dey  
et al.25 evaluated antioxidant activity, preliminary 
phytochemical analysis, total phenolic content and total 
flavonoids content of Bambusa tulda leaves. Though as 
per our knowledge, there is no substantial scientific 
evidence found on the in vivo anti-diabetic activity. 
Therefore, with this understanding, the current investigation 
could be the one to analyze the antihyperglycemic and 
antioxidative properties of Bambusa tulda leaf extract in 
alloxan-induced diabetic rats. 
 
Materials and Methods  
 
Plant material collection and extraction 
The leaves of Bambusa tulda (BT) were amassed 
from the forest of Kokrajhar District, BTAD, Assam, 
(Latitude: 26°23'59.99"N, Longitude: 90° 16' 7.20" E) 
India during July, 2016. After an authentication by a 
plant taxonomist a voucher specimen (Voucher No. 
DBT/BU/Bamboo/007) was placed at Bodoland 
University herbarium, Kokrajhar, BTAD, Assam, India. 
The air-dried bamboo leaves were finely ground 
using an indigenous mechanical grinder. Ten-gram of 
powdered sample was extracted using a Soxhlet 
apparatus with 70% aqueous methanol (v/v) (the ratio 
of plant matter to solvent was 1:15 m/v)27 for 6 h in 
three cycles. The extract obtained was dried under 
pressure at 50°C to get a steady weight and stored  
at 4°C until required. Before use, the extract was 
suspended in double-distilled water (DDW) in the 
desired concentrations25. 
 
In vivo activity 
 
Experimental animals 
Male Wistar albino rats (200-250 g) and Swiss mice 
(25-30 g) were adapted at 26±3°C, relative humidity of 
62±5% and 12:12-h light–dark cycle. The animals were 
kept on a regular rat chow-chow diet (Lipton India Ltd., 
Bengaluru) and tap water ad libitum. The standard 
procedural routines were followed, once the consent was 
provided by Maharani Lakshmi Ammanni College 
Internal Animal Ethical Committee, Bengaluru 
(1368/ac/10/CPCSEA/SKM/ BT/17) and were in 
compliance with the guidelines approved by the 
Committee for the Purpose of Control and Supervision 
of Experiments on Animals (CPCSEA) for the care and 
utilization of laboratory animals. 
 
Acute toxicity test 
The randomly segregated Swiss mice (25-30 g) of 
any sex were fasted (n=10 animals per group) overnight 
and made accessible prior to the toxicological trial. The 
hydro-methanolic extract of BT leaf extract having 
diverse dose levels (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 
4.5, 5.0 g/kg BW/mL) were orally supplemented once 
per day to experimental groups as indicated previously 
by our group28. The experimental mice were kept under 
observation for next 48 h, any casualties were recorded 
and the median lethal dose LD50 was studied using 
OECD guidelines and as our previous study8. The 
following formula was used for calculating LD50: LD50 = 
Highest dose (LDy) – I-rΣ [Dose difference (Dd) X Mean 
dead (Md)]/ number of animals per group (n)  
 




After a week of acclimation, rats were prepared/ 
induced diabetic using alloxan (2,4,5,6(1H,3H)-
Pyrimidinetetrone) (150 mg/kg BW/mL i.p.) in  
50 mM phosphate buffer Saline (pH 7.2) in overnight 
fasted animals excluding normal animal group. To avoid 
initial alloxan-induced lethal hypoglycemia, rats were 
administered glucose (5 mL of 10% solution) using 16 
gavage (16 g) ball point needle and were permitted 5% 
glucose in drinking water subsequently for 24 h. Rats 
which had fasting blood sugar (FBS) less than 220-260 
dL/mL were excluded from the experiment. Others were 
included as diabetic animals and used further for 
experimental purposes and were randomly grouped into 
5 groups29. The groups include DC (Diabetic control), 
LBT (100 mg/kg BW/mL, lower dosage of B. tulda), 
HBT (200 mg/kg BW/mL, higher dosage of B. tulda), 
DG (5 mg/kg BW/mL; Diabetic glibenclamide) and DI 
(Diabetic insulin) groups, each having 6 rats per group. 
Rats (n=6) neither treated with alloxan nor with extract 
were considered as a normal (NL) group. NL and DC 
groups received distilled water until the experiment 
ended. LBT and HBT groups were orally fed with  
100 mg/kg BW and 200 mg/kg BW hydro-methanolic 
extract of B. tulda leaf, respectively. DG and DI were 
included as Positive control groups and treated with 
standard drug glibenclamide (600 µg/kg BW) and 
insulin (2 units/ kg of BW) (Insugen, Biocon) daily 
intraperitoneally (i.p.), respectively. All the groups were 
treated in a similar pattern for six continuous weeks. 
FBS was found out after the 7th day and last week before 
sacrifice. Body weight (BW) was determined on a daily 
basis. After 6 weeks, testing animals were euthanized 
using standard protocol (0.3 mL/100 g i/p Ketamine 
(300 mg/kg) + 0.15 mL/100 g Xylazine (30 mg/kg)) as 
recommended by IAEC (CPCSEA) and liver tissue was 
used for further biochemical assays11. 




Estimation of blood glucose 
Blood withdrawn from overnight fasted trail animals, 
were used to check FBS by using one touch automated 
ACCU-CHEK® blood glucose meter check29.  
 
Preparation of tissue 
The 5% crude liver homogenate was obtained  
for malondialdehyde (MDA) assay, a marker of  
lipid peroxidation. The 5% homogenate centrifuged 
(Eppendorf 5810R, Germany) and collected, at 600 xg 
for 10 min, were used for antioxidant enzyme estimation 




All analysis followed in methodology was 
performed in triplicates and articulated as mean ± 
Standard Error (SE). Relationships amid diverse 
experimental groups were established using one-way 
ANOVA using MS Excel at p<0.05. 
 
Results and Discussion 
Plants have been postulated and fondly acting as 
conventional medicine since the time immemorial. 
They are understood to be the major components of 
several formulations (herbal) that could help in 
reducing a range of health ailments. Therefore, a 
comprehensive learning on medicinal plants is in 
spotlight for the progression and quality management 
of traditional formulations. 
Ying et al.30, previously reported that bamboo leaf 
extract might exert anti-diabetic activity because of its 
effect on the improvement of insulin sensitivity 
although without a significant change in HbA1C 
values in streptozotocin (STZ)-induced animal model. 
There was nothing reported about the dosage toxicity 
and pancreatic anatomy in that study. In this context, 
the current research may offer a promising strategy  
to understand the acute toxicity, in vivo anti-
hyperglycemic and antioxidative activity of hydro-
methanolic extract of B. tulda leaf native to Bodoland, 
India. 
 
In vivo studies 
 
Acute toxicity test 
LD50 of BT leaf extract was 6088.13 mg/kg BW in 
mice. There were not many reports with regards to 
toxicity studies of BT. Earlier, Goyal et al.11 have 
reported the LD50 value of B. balcooa (5.18 g/kg 
BW). The loss of locomotors activity noticed after  
12 h of the drug administration indicated the toxicity 
of the extract. However, no mortality was seen in 
experimental animals for the given dosages. Loomis 
and Hayes scale31 indicated a chemical entity ranging 
within 5–15 g/kg BW, is regarded as practically non-
toxic and relatively safe11,32. 
 
Effect of hydro-methanolic extract of BT leaves on glucose level 
A significant anti-hyperglycemic bustle was noted 
from the third day onwards (Table 1). The decrease 
was prominent up to the 6th week (42nd day) in 
experimental animals receiving the high dose of BT, 
though the results were not found significant. A 
significant (p<0.05) increase in FBS was recorded 
after alloxan administration when compared to  
NL group. The BT supplementation significantly 
(p<0.001) trimmed down the blood glucose levels in 
hyperglycemic animals when compared to the DC 
group. The HBT was noted to be more effective than 
the LBT, indicating that HBT has strong anti-diabetic 
activity and acted as an efficient dose. Goyal et al.11 
also have evaluated and found similar pattern in  
B. balcooa leaves extract. Earlier, the anti-
hyperglycemic activity of Bambusa arundinacea 
leaves was evaluated by the Nazreen and coworkers33 
in streptozotocin (STZ) induced diabetic animals. Dey 
et al.34 reported the preliminary anti-hyperglycemic 
activity of B. tulda in alloxan induced animals.  
 
Biochemical assays 
The SOD and GPx concentration of distilled water 
(normal) and extract-treated animals were studied in 
hepatic (liver) tissue (Fig. 1 and 2). In diabetic rats, 
the SOD activities were significantly lowered than the 
NL control group (Fig. 1). Oral supplementation of 
BT extract revealed an increase in SOD activity.  
A similar trend was observed in DG and DI groups 
Table 1 — Blood glucose level (mg/dL) in experimental  
diabetic rats 
Group 0th Day 3rd Day 42nd Day 
NL 99±2.91 93±2.11 99±3.52 
DC 101±1.31 280±6.91a 391±5.43a 
DG 102±2.51 276±7.81a 219±6.48b 
DI 103±1.89 285±4.53a 124±4.32c 
LBT (100 mg/kg) 101±2.61 286±8.96a 224±8.61b 
HBT (200 mg/kg) 100±2.11 278±5.73a 204±5.27b 
Abbreviations indicates NL, Normal; DC, Diabetic Control; DG,
Diabetic glibenclamide, DI, Diabetic insulin; LBT (100 mg/kg), 
Lower dosage of B. tulda; HBT(200 mg/kg), Higher dosage of 
B. tulda. The values are means + S.E. (n=6 animals/groups) in
the liver of experimental animals. Results (columns-wise) 
were considered significant between the groups at p<0.05 in a 
comparative study with DC. Those are not sharing the common
letters (a & b) are significantly different. 




with significant effects compared to DC group. 
Similarly, GPx activity was moderated in DC group 
(Fig. 2). A significant Increase in GPx activity was 
seen in rats treated with HBT extract (but not with 
LBT). HBT had increased the levels of SOD 
(24.81%) and GPx (31.60%) antioxidant enzymes in 
the liver. This study underlines that these enzymes are 
inter-related and lowering their enzymatic activity can 
directly amplify oxidative stress in the alloxan-treated 
diabetic animals. The BT extract treatment (at least at 
high dose) can improve the activity of these enzymes 
radically and might assist in getting rid of the free 
radicals spawned during diabetes mellitus. Lv et al.35 
reported a boost in antioxidant enzymes such as SOD 
and GPx activity in hepatic tissue (liver), when the 
STZ-induced diabetic rats were supplemented with 
Dendrocalamopsis oldhamii extract. Ying et al.30 
proved that supplementing bamboo could reduce 
weight and glucose level in hyperglycemic rats. The 
decreased glycosylated hemoglobin A1c (HbAlc) and 
increasing SOD activity were also observed in their 
study following the supplementation.  
A significant decrease of MDA in the liver with the 
higher dose of BT was recorded when compared  
with DC group animals (Fig. 3). MDA is known to be 
the end product of poly-unsaturated fatty acid 
peroxidation, whose fabrication augments with the 
amplification in free radicals. In this study, the DC 
group demonstrated a noteworthy increase in MDA as 
compared to the NL group. Supplementation of BT 
extract lowered the lipid peroxidation (LPx). The 
effect of the standard drug (DG group) was found to 
be more significant (34.1%) than the rats treated with 
BT (21.9%). The results reported in this study are in 
agreement with the previous report on the giant 
grass11. Lipid peroxidation level (MDA) was also seen 
decreasing in diabetic animals after bamboo leaf 
extract supplementation. The group also indicated that 
bamboo leaf supplementation could improve diabetic 
nephropathy conditions by triggering the protein 
kinase B (AKT) pathway in investigational animals. 
Nazreen and her co-workers33 indicated the anti-
hyperglycaemic properties of Bambusa sp. in STZ-
induced diabetic models. Their study confirmed a 
reduction in FBS in experimentally treated animals, 
followed by the reduction in the GPx level and thus 
elevating the enzyme activity. Another report by Lv 
 
 
Fig. 1 — Effect of B. tulda leaf extract supplementation on
superoxide dismutase in liver of experimental rats. Values are
means + S.E. (n=6 animals/groups) in the liver of experimental
animals. Results were considered significant between the groups
at p<0.05 in a comparative study with DC. Those are not sharing




Fig. 2 — Effect of B. tulda leaf extract supplementation on
glutathione peroxidase in liver of experimental rats. Values are
means + S.E. (n=6 animals/groups) in the liver of experimental
animals. Results were considered significant between the groups
at p<0.05 in a comparative study with DC. Those are not sharing




Fig. 3 — Effect of B. tulda leaf extract supplementation on lipid
peroxidation in the liver of experimental rats. Values are means + 
S.E. (n=6 animals/groups) in the liver of experimental animals.
Results were considered significant between the groups at p<0.05
in a comparative study with DC. Those are not sharing the 
common letters (a & b) are significantly different. 
 




and his team35 on Dendrocalamopsis oldhamii extract, 
observed a significant reduction in the antioxidative 
enzymes like SOD and GPx, in the liver after the 
animals were treated with the same. The same study 
also proposed that the animals in the DC group 
(diabetic) are in depiction to oxidative stress. They 
also indicated that D. oldhamii extract could moderately 
decrease the inequities between the generation of 
reactive oxygen species (ROS) and the foraging 
enzyme activity. Goyal and his co-workers11 also 
substantiated the anti-hyperglycaemic and antioxidant 
potential of Bambusa balcooa in alloxan-induced 
diabetic rats. 
Escalating confirmation ties the pathological 
transformations of pancreatic tissue with high glucose- 
stimulated, even though the fundamental mechanism 
remains unclear with regards to complementary  
and alternative medicines treatment36-39. To more 
profoundly understand the beneficial effect of the 
bamboo extract on diabetic rats, authors utilized histo-
pathological evidence to prove their claim (Fig. 4). 
Result evidenced that diabetic rats have deteriorated 
changes in the β-cells of pancreases after alloxan 
treatment. Conversely, the animals treated with 
bamboo leaf extract could reverse β-cells of pancreases 
with little side-effect such as hair fall noticed. The 
data recorded here clearly demonstrated that bamboo 
leaf extract moderately shields pancreatic tissue 
against diabetes and its side effects. 
 
Conclusions 
To conclude, it could be understood from the  
above learning that Bambusa tulda leaf could be 
complemented as an antioxidant remedy due to its 
similar insulin-like activity and may provide evidence in 
eliminating the hyperglycemia and averting side effects 
due to diabetes including free radicals. This could 
possibly be attributed to the synergistic effect of the 
various bioactive phyto-constituents recorded in 
Bambusa tulda leaf like p-hydroxy benzoic acid, 
salicylic acid, o-coumaric acid, vanillic acid, ferulic acid 
and 2,4-dihydroxybenzoic acid as reported by Dey and 
his team in their previous study23. However, further 
studies at molecular level have to be carried out to prove 
its anti-diabetic efficiency and to bring out a drug 
molecule from the extract and to understand the extract’s 
molecular mechanism of function. 
 
Limitations/Future directions 
Here, the readers must understand the limitations of 
this study, hence can be taken as future directions. In 
this work, the authors have only indicated the 
probable pathway using histopathological studies 
indicating partially growing pancreatic β -cells. Thus, 
other signalling pathways, such as Akt, or linked 
pathways that improve diabetes conditions, may also 
be involved. The bioactive constituents of the leaf 
extract of BT should be elucidated to correlate with 
the observed anti-diabetic activity which can help us 
to study the activity guided fractionation of the extract 
for further confirmation. Using gene knock-out 
animals and inhibitors, researchers may able to clearly 
confirm the efficacy of bamboo extract in alleviating 
diabetic symptoms. In-vitro trials (cell lines) will be 
continued further to convolute specific mechanisms 
whereby bamboo extract reduces the injuries 
persuaded by elevated sugar levels. This work was 
conducted with male animals and thus effect of the 
extracts on the female rats should also be studies in 
the future. It needs another trail in either sex (female) 
rats also. Furthermore, data of this research were all 
obtained from preclinical study and the prospective 
 
 
Fig. 4 — Histopathology of pancreas stained by haematoxylin (H)
and eosin (E) stain of (a) Normal control: Normal control group
display the normal islet (arrow) (b) Diabetic control: Diabetic
control rat histopathology display the islet enlargement and
necrosis (arrow) (c) LBT (100 mg/kg BW): BT tested drug
histopathology display increasing islets and necrosis (arrow) (d)
HBT (200 mg/kg BW) (e) Glibenclamide (400 µg/kg BW):
Glibenclamide treated group rat histopathology showing normal
islet close to the normal control group (f) Insulin (1 U/kg BW):
The histopathology images of insulin-treated group rat pancreas
showing normal islet close to normal control animal group. For
each group 6 animals were examined and 30 photos were
captured. (Original magnification, 40 X) 
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